An updated analysis of the randomized phase III trial found no survival benefit from the addition of pelvic radiation to chemotherapy in stage III endometrial cancer. Historically, such patients received radiotherapy to prevent pelvic recurrence, but in recent years systemic chemotherapy proved to be highly active.
Novel U.S. vaccines are tested against placebos, despite recent suggestions to the contrary
In contrast to relapsing‐remitting patterns, persistently active disease (PAD) is a disease activity pattern in patients with systemic lupus erythematosus (SLE) that is inadequately studied.…
According to the results of a new study from Japan, the size of lymph nodes on preoperative computed tomography in patients with resectable colon cancer…
Acute severe ulcerative colitis (ASUC) is associated with a significant risk of colectomy and requires timely and effective medical intervention to reduce morbidity and mortality.…
Accreditation must remain independent to protect equity in medicine
Single-arm trial shows steroid-sparing for most patients
Recent developments of interest in cardiovascular medicine
Zasocitinib, a tyrosine kinase 2 (TYK2) inhibitor, holds promise as a new oral treatment for psoriasis, randomized clinical trial data suggest. Results of the multisite…
Their leadership must be grounded in sound public health priorities
Rare kidney disease still lacks an FDA-approved therapy
